Home > Insider Trading > Intellia Therapeutics Inc.

Intellia Therapeutics Inc. (NTLA)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

1 - 10
Next >>

10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds

The pharmaceutical industry remains a hub of patent innovation, driven by evolving treatment paradigms, unmet medical needs, and the rising influence of technologies like pharmacogenomics, digital therapeutics...

Keep Reading →

October 30th, 2024 - Hedge Funds Industries News

10 Most Promising Biotech Stocks According to Hedge Funds

Biotechnology stocks are known for their high risk, making them some of the most volatile in the market.

Keep Reading →

October 11th, 2024 - Hedge Funds Industries News

10 Stocks That Will Change the World

If we were to try and summarize one of the biggest ways how to make money on the stock market, it'd include buying stocks of firms that have changed the world.

Keep Reading →

August 13th, 2024 - Market Movers News

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2024 Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q2 2024 Earnings Call Transcript August 8, 2024Intellia Therapeutics, Inc. misses on earnings expectations.

Keep Reading →

August 9th, 2024 - News Transcripts

Is Intellia Therapeutics, Inc. (NASDAQ:NTLA) the Most Promising Gene Therapy Stock to Buy Now?

We recently compiled a list of the 9 Best Gene Therapy Stocks to Buy Now and in this article, we discuss whether Intellia Therapeutics, Inc.

Keep Reading →

June 3rd, 2024 - Hedge Funds News

9 Best Gene Therapy Stocks to Buy Now

In this article, we will be discussing the best gene therapy stocks to buy now. Before we move on to our list, let's take a look at the market outlook for gene therapies and understand the reasons behind...

Keep Reading →

June 3rd, 2024 - Hedge Funds News Stock Analysis

15 Best ARK Stocks To Buy Now

Cathie Wood is one of the most polarizing, and prominent figures on Wall Street.

Keep Reading →

May 13th, 2024 - Hedge Funds News

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q1 2024 Earnings Call Transcript

Operator: Good morning, and welcome to Intellia Therapeutics’ First Quarter 2024 Financial Results Conference Call. My name is Drew, and I will be your conference operator today.

Keep Reading →

May 10th, 2024 - News Transcripts

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q4 2023 Earnings Call Transcript

Intellia Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.46, expectations were $-1.47. Intellia Therapeutics, Inc.

Keep Reading →

February 23rd, 2024 - News Transcripts

Top 11 CRISPR Stocks To Invest In

Genome editing refers to a set of technologies enabling scientists to modify an organism's DNA by adding, removing, or altering genetic material at specific locations in the genome, as defined by MedlinePlus...

Keep Reading →

February 10th, 2024 - Hedge Funds News